Bodiou Vincent, Moutsatsou Panagiota, Post Mark J
Department of Physiology, Faculty of Health, Medicine and Life Sciences, School for Cardiovascular Diseases, Maastricht University, Maastricht, Netherlands.
Mosa Meat BV, Maastricht, Netherlands.
Front Nutr. 2020 Feb 20;7:10. doi: 10.3389/fnut.2020.00010. eCollection 2020.
Due to the considerable environmental impact and the controversial animal welfare associated with industrial meat production, combined with the ever-increasing global population and demand for meat products, sustainable production alternatives are indispensable. In 2013, the world's first laboratory grown hamburger made from cultured muscle cells was developed. However, coming at a price of $300.000, and being produced manually, substantial effort is still required to reach sustainable large-scale production. One of the main challenges is scalability. Microcarriers (MCs), offering a large surface/volume ratio, are the most promising candidates for upscaling muscle cell culture. However, although many MCs have been developed for cell lines and stem cells typically used in the medical field, none have been specifically developed for muscle stem cells and meat production. This paper aims to discuss the MCs' design criteria for skeletal muscle cell proliferation and subsequently for meat production based on three scenarios: (1) MCs are serving only as a temporary substrate for cell attachment and proliferation and therefore they need to be separated from the cells at some stage of the bioprocess, (2) MCs serve as a temporary substrate for cell proliferation but are degraded or dissolved during the bioprocess, and (3) MCs are embedded in the final product and therefore need to be edible. The particularities of each of these three bioprocesses will be discussed from the perspective of MCs as well as the feasibility of a one-step bioprocess. Each scenario presents advantages and drawbacks, which are discussed in detail, nevertheless the third scenario appears to be the most promising one for a production process. Indeed, using an edible material can limit or completely eliminate dissociation/degradation/separation steps and even promote organoleptic qualities when embedded in the final product. Edible microcarriers could also be used as a temporary substrate similarly to scenarios 1 and 2, which would limit the risk of non-edible residues.
由于工业化肉类生产对环境造成的重大影响以及与之相关的备受争议的动物福利问题,再加上全球人口不断增长以及对肉类产品的需求持续增加,可持续的生产替代方案必不可少。2013年,世界上第一个由培养的肌肉细胞制成的实验室培育汉堡问世。然而,其造价高达30万美元,且为手工制作,要实现可持续的大规模生产仍需付出巨大努力。其中一个主要挑战是可扩展性。微载体具有较大的表面积与体积比,是扩大肌肉细胞培养规模最有前景的候选材料。然而,尽管已经开发出许多适用于医学领域常用细胞系和干细胞的微载体,但尚未有专门为肌肉干细胞和肉类生产开发的微载体。本文旨在基于三种设想讨论微载体用于骨骼肌细胞增殖进而用于肉类生产的设计标准:(1)微载体仅作为细胞附着和增殖的临时基质,因此在生物过程的某个阶段需要与细胞分离;(2)微载体作为细胞增殖的临时基质,但在生物过程中会降解或溶解;(3)微载体嵌入最终产品中,因此需要可食用。将从微载体的角度以及一步法生物过程的可行性来讨论这三种生物过程各自的特点。每种设想都有其优缺点,将进行详细讨论,不过第三种设想似乎是生产过程中最有前景的。的确,使用可食用材料可以限制或完全消除解离/降解/分离步骤,甚至在嵌入最终产品时提升感官品质。可食用微载体也可以像设想1和2那样用作临时基质,这将降低不可食用残留物的风险。